Potential modulation of microglial ferroptosis by Linggui Zhugan decoction in Alzheimer's disease through IL-17 and TNF pathways
International Immunopharmacology · 2025-11 · 165 · 115489
DOI: 10.1016/j.intimp.2025.115489 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025-11. Verfasst von Peng Tang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Chengdu Integrated TCM & Western Medicine Hospital, Chengdu 610000, China. Hauptthemen laut MEDLINE: Ferroptosis, Alzheimer Disease, Microglia, Drugs, Chinese Herbal. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 69 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's Disease (AD) is a neurodegenerative condition marked by cognitive decline and memory loss, with ferroptosis, an iron-dependent form of regulated cell death, emerging as a contributing factor. This study explored the potential modulatory effects of key components of the traditional Chinese medicine (TCM) formula Linggui Zhugan Decoction (LZD) on microglial ferroptosis in AD, focusing on IL-17 and TNF signaling pathways. Using single-cell RNA sequencing, we observed alterations in microglial populations and ferroptosis-related gene expression in AD mice. Network pharmacology and in vitro experiments indicated that LZD components might influence ferroptosis-related pathways, coinciding with reduced IL-17 and TNF levels in Aβ1-42-treated microglia. In vivo, LZD administration was associated with improved behavioral outcomes and modulation of ferroptosis markers. Although our findings suggest a correlation between LZD treatment and attenuation of ferroptosis-associated pathology, further mechanistic validation is necessary to establish causal links. This study provides preliminary evidence supporting the therapeutic potential of TCM in AD via inflammatory pathway modulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Chengdu Integrated TCM & Western Medicine Hospital, Chengdu 610000, China.
- Department of Pharmacy, The First People's Hospital of Shuangliu District, West China (Airport) Hospital of Sichuan University, Chengdu 610000, China.
- Department of Pharmacy, Chengdu Integrated TCM & Western Medicine Hospital, Chengdu 610000, China. Electronic address: 871122479@qq.com.
- Department of Pharmacy, Gansu Provincial Hospital of Traditional Chinese Medicine, Lanzhou 730050, China. Electronic address: chenhbin11@163.com.
Zitieren
APA
Tang, P., Zhao, D., Lin, H., Li, X., Shi, C., Li, P., & Chen, H. (2025). Potential modulation of microglial ferroptosis by Linggui Zhugan decoction in Alzheimer's disease through IL-17 and TNF pathways. International Immunopharmacology, 165, 115489. https://doi.org/10.1016/j.intimp.2025.115489
Vancouver
Tang P, Zhao D, Lin H, Li X, Shi C, Li P, et al. Potential modulation of microglial ferroptosis by Linggui Zhugan decoction in Alzheimer's disease through IL-17 and TNF pathways. International Immunopharmacology. 2025;165:115489. doi:10.1016/j.intimp.2025.115489
BibTeX
@article{Tang2025,
author = {Tang, Peng and Zhao, Danjie and Lin, Haixia and Li, Xia and Shi, Chongjing and Li, Ping and Chen, Huibin},
title = {Potential modulation of microglial ferroptosis by Linggui Zhugan decoction in Alzheimer's disease through IL-17 and TNF pathways},
journal = {International Immunopharmacology},
year = {2025},
volume = {165},
pages = {115489},
doi = {10.1016/j.intimp.2025.115489}
}
EUVIMED